Please try another search
For the six months ended 30 June 2021, AvisaDiagnostics Inc revenues decreased from $278K to $0K. Netloss increased from $489K to $3.3M. Revenues reflect adecrease in demand for the Company's products and servicesdue to unfavorable market conditions. Higher net lossreflects Consulting fees increase from $0K to $293K(expense), Salaries and benefits increase of 40% to $444K(expense), Travel increase from $1K to $34K (expense).
Period Ending: | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | -0 | |
Operating Income | -4.47 | -0.33 | -0.12 | -0.1 |
Net Income | -4.53 | 1.19 | -0.12 | -0.1 |
Period Ending: | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
---|---|---|---|---|
Total Assets | 2.83 | 0.19 | 0.12 | 0.18 |
Total Liabilities | 3.61 | 0.77 | 0.65 | 0.59 |
Total Equity | -0.79 | -0.59 | -0.53 | -0.41 |
Period Ending: | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
---|---|---|---|---|
Period Length: | 6 Months | 3 Months | 12 Months | 9 Months |
Cash From Operating Activities | -0.87 | -0.04 | -0.45 | -0.48 |
Cash From Investing Activities | 0.12 | 0 | 0 | |
Cash From Financing Activities | -0.55 | 0.11 | 0.14 | 0.2 |
Net Change in Cash | -1.3 | 0.07 | -0.32 | -0.28 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review